MX362592B - Supresion de olor de los compuestos analgesicos organicos volatiles y metodo de uso. - Google Patents

Supresion de olor de los compuestos analgesicos organicos volatiles y metodo de uso.

Info

Publication number
MX362592B
MX362592B MX2015008800A MX2015008800A MX362592B MX 362592 B MX362592 B MX 362592B MX 2015008800 A MX2015008800 A MX 2015008800A MX 2015008800 A MX2015008800 A MX 2015008800A MX 362592 B MX362592 B MX 362592B
Authority
MX
Mexico
Prior art keywords
volatile organic
properties
analgesic
odor
odor suppression
Prior art date
Application number
MX2015008800A
Other languages
English (en)
Other versions
MX2015008800A (es
Inventor
TER-ANTONYAN Vardan
Sondgeroth Jason
Jaeger David
Smith Shane
BARNES Elisa
Original Assignee
Chattem Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chattem Inc filed Critical Chattem Inc
Publication of MX2015008800A publication Critical patent/MX2015008800A/es
Publication of MX362592B publication Critical patent/MX362592B/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/047—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates having two or more hydroxy groups, e.g. sorbitol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/12—Ketones
    • A61K31/122—Ketones having the oxygen directly attached to a ring, e.g. quinones, vitamin K1, anthralin
    • A61K31/125—Camphor; Nuclear substituted derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/60—Salicylic acid; Derivatives thereof
    • A61K31/618—Salicylic acid; Derivatives thereof having the carboxyl group in position 1 esterified, e.g. salsalate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A61K36/906—Zingiberaceae (Ginger family)
    • A61K36/9068—Zingiber, e.g. garden ginger
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L9/00—Disinfection, sterilisation or deodorisation of air
    • A61L9/01—Deodorant compositions
    • A61L9/013—Deodorant compositions containing animal or plant extracts, or vegetable material

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Medical Informatics (AREA)
  • Botany (AREA)
  • Biotechnology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Se describen las composiciones analgésicas de supresión de olor, que comprenden: a) de aproximadamente 0.1% a aproximadamente 20%, en peso, de farnesol o de otro agente bacterioestático desodorizante conveniente; y b) de aproximadamente 0.1% a aproximadamente 60%, en peso, de compuesto orgánico volátil donde dicho compuesto orgánico volátil puede encapsularse y se elige de los siguientes (mentol, alcanfor, salicilato metilo, nicotiniato de metilo, o combinación de los mismos); y c) una emulsión de agua en aceite o de aceite en agua, gel, parche, pasta, ungüento, solución o rocío. Una optimizada composición analgésica de supresión de olor puede proporcionar una combinación de propiedades antimicrobianas, de propiedades de supresión de olor, de propiedades de enfriamiento o de calentamiento de la piel, de propiedades analgésicas tópicas, de baja irritación y de estabilidad.
MX2015008800A 2013-01-08 2014-01-07 Supresion de olor de los compuestos analgesicos organicos volatiles y metodo de uso. MX362592B (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US13/736,454 US8697043B1 (en) 2013-01-08 2013-01-08 Odor suppression of volatile organic analgesic compounds and method of use
PCT/US2014/010500 WO2014110035A1 (en) 2013-01-08 2014-01-07 Odor suppression of volatile organic analgesic compounds and method of use

Publications (2)

Publication Number Publication Date
MX2015008800A MX2015008800A (es) 2016-08-08
MX362592B true MX362592B (es) 2019-01-25

Family

ID=50441375

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2015008800A MX362592B (es) 2013-01-08 2014-01-07 Supresion de olor de los compuestos analgesicos organicos volatiles y metodo de uso.

Country Status (4)

Country Link
US (1) US8697043B1 (es)
MX (1) MX362592B (es)
WO (1) WO2014110035A1 (es)
ZA (1) ZA201504787B (es)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2017044762A1 (en) * 2015-09-10 2017-03-16 Aranki Tania Topical analgesic
CA3026108A1 (en) 2016-06-10 2017-12-14 Clarity Cosmetics Inc. Non-comedogenic hair and scalp care formulations and method for use

Family Cites Families (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5467022A (en) 1977-11-07 1979-05-30 Toko Yakuhin Kogyo Kk Topical agent and production thereof
AU5341390A (en) * 1989-03-17 1990-10-22 Nastech Pharmaceutical Co. Topical analgesic composition
JP2523428B2 (ja) * 1992-12-04 1996-08-07 エスエス製薬株式会社 消炎鎮痛ゲル製剤
US5536263A (en) 1994-03-30 1996-07-16 Lectec Corporation Non-occulusive adhesive patch for applying medication to the skin
JP3908795B2 (ja) 1994-11-29 2007-04-25 久光製薬株式会社 ケトチフェン含有経皮投与製剤
JP3827195B2 (ja) * 1998-08-10 2006-09-27 株式会社日本ハイポックス 消炎鎮痛剤
CN1235572C (zh) 1999-12-15 2006-01-11 久光制药株式会社 贴剂
US6774100B2 (en) * 2000-12-06 2004-08-10 Imaginative Research Associates, Inc. Anhydrous creams, lotions and gels
CA2446060A1 (en) * 2001-05-07 2002-11-14 Corium International Compositions and delivery systems for administration of a local anesthetic agent
US20020192273A1 (en) 2001-06-15 2002-12-19 Teri Buseman Therapeutic patch useful for the treatment of hemorrhoids
JP4167834B2 (ja) 2002-01-25 2008-10-22 久光製薬株式会社 粘着剤およびこれを用いてなる貼付製剤
US6579543B1 (en) 2002-02-22 2003-06-17 Jackie H. McClung Composition for topical application to skin
US7235261B2 (en) * 2002-06-27 2007-06-26 Haarmann & Reimer Corporation Controlled release encapsulation
EP1514539A3 (en) 2003-05-14 2005-05-04 Signal Investment & Management Co. Micro-encapsulated topical analgesic for pain relief and sleeve comprising it
WO2005037946A1 (ja) * 2003-10-20 2005-04-28 Hisamitsu Pharmaceutical Co., Inc. 皮膚外用貼付剤
WO2005065668A2 (en) 2003-12-29 2005-07-21 Qlt Usa, Inc. Topical compositions comprising halo-deoxyadenosines for treatment of skin disorders
EP1992367B1 (en) 2007-05-15 2012-06-27 The Procter & Gamble Company Absorbent article comprising a lotion composition for reducing adherence of feces or menses to the skin
US8846063B2 (en) 2008-12-16 2014-09-30 Kimberly-Clark Worldwide, Inc. Personal care composition containing a volatile and a terpene alcohol
WO2010103844A1 (ja) 2009-03-11 2010-09-16 興和株式会社 鎮痛・抗炎症剤含有外用剤
WO2009087242A2 (en) * 2009-04-09 2009-07-16 Symrise Gmbh & Co. Kg Compositions comprising trans-tert-butyl cyclohexanol as skin irritation-reducing agent
US9029415B2 (en) 2010-06-14 2015-05-12 Symrise Ag Cooling mixtures with an enhanced cooling effect of 5-methyl-2-(propane-2-yl)cyclohexyl-N-ethyloxamate
EP2286908A3 (de) 2010-11-19 2011-06-01 Symrise AG Lösungsvermittler für kosmetische Zubereitungen
EP2457554A1 (de) * 2010-11-24 2012-05-30 Symrise AG Menthol enthaltende Mischung
US20120213717A1 (en) * 2011-02-18 2012-08-23 Mcneil-Ppc, Inc. Soothing Agents

Also Published As

Publication number Publication date
US8697043B1 (en) 2014-04-15
ZA201504787B (en) 2019-12-18
WO2014110035A1 (en) 2014-07-17
MX2015008800A (es) 2016-08-08

Similar Documents

Publication Publication Date Title
MX2017004256A (es) Metodo para desinfectar semillas comestibles, particularmente semillas productoras de mucilago.
BR112015019657A2 (pt) composições tópicas e métodos de uso das mesmas
BR122021018243A8 (pt) Composição tópica de baixo ph e método para aumentar a aplicação tópica de um ingrediente ativo cosmeticamente aceitável
CO7101251A2 (es) Derivado de sulfuro de alquil fenilo y agente de control de plagas
EA201591003A1 (ru) Производные бороновой кислоты и их терапевтическое применение
WO2014113429A3 (en) Substituted pyrrolopyrimidine compounds, compositions thereof, and methods of treatment therewith
TR201904455T4 (tr) Nükleer taşıma modülatörleri olarak 1,2,4-triazoller ve bunların kullanımları.
GB201021937D0 (en) Skin sanitizer compositions comprising alcohol based emulsion
NZ716840A (en) Combination formulation of two antiviral compounds
PH12015502802A1 (en) Formulation comprising a hypolipidemic agent
MX2015013051A (es) 1-hidroxi-benzooxaboroles como agentes antiparasitarios.
RU2014130012A (ru) Композиции, содержащие экстракт malva neglecta
GB2476446A (en) Topical treatment of skin infection
MX2013010308A (es) 2,4-pirimidindiaminas sustituidas para uso en lupus discoide.
MX2016004909A (es) Composicion que contiene eugenol como principio activo para prevenir o tratar la dermatitis atopica.
BR112015027436A8 (pt) composição tópica e veículo para administração de ingredientes farmaceuticamente ou cosmeticamente ativos
MX2015012455A (es) Metodo para el tratamiento de la enfermedad de higado graso.
MX362592B (es) Supresion de olor de los compuestos analgesicos organicos volatiles y metodo de uso.
MX2012013642A (es) Composiciones farmaceuticas topicas que comprenden furoato de mometasona.
MX2016008546A (es) Reduccion de queloides utilizando alantoina topica.
BR112014017448A2 (pt) composição dermocosmética contendo como princípio ativo, uma combinação sinérgica de prata coloidal e ácido desoxirribonucleico
BR112019002344A2 (pt) composto de 1-fenil-3-carbamoilureia e uso do mesmo
NI201200196A (es) Agentes terapéuticos 976
BR112012022607A2 (pt) composição inseticida e método para controlar insetos usando a mesma
WO2015035530A8 (es) Composición desinfectante del tipo gel para manos y piel, de secado rápido, que no contiene alcohol

Legal Events

Date Code Title Description
FG Grant or registration